NEWS & VIEWS

Global private equity and venture capital news and research

China’s CITIC Private Equity completes $370m take-private of 3SBio

3 Jun 2013

China’s CITIC Private Equity has completed a $370m take-private of Nasdaq-listed biotechnology company 3SBio.

The company focuses on researching, developing, manufacturing and marketing biopharmaceutical products. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people.

CITIC funded the deal through its China-focused private equity vehicle CPEChinaFund, alongside debt. The acquisition was made via a special purpose vehicle named Decade Sunshine

Back in February Decade Sunshine and CITIC made take-private offers for 3SBio, valuing it at $15.40 per ADS, or $340m.

Holders of the company’s ordinary shares and American depositary shares (ADS) received $2.39 a share or $16.70 per ADS, a 44 per cent premium over 3SBio’s September share price and per cent over the April share price following a revised offer.

Copyright © 2013 AltAssets

 

FUNDRAISING & INVESTOR RELATIONS


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014